1. Prognostic value of SUVmax measured by pretreatment 18F-FDG PET/CT in patients with primary gastric lymphoma. Hwang JP, Lim I, Byun BH, Kim BI, Choi CW, Lim SM. Nucl Med Commun. 2016 Dec;37(12):1267-1272.

2. Prognostic Value of SUVmax Measured by Pretreatment Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Ewing Sarcoma. Hwang JP, Lim I, Kong CB, Jeon DG, Byun BH, Kim BI, Choi CW, Lim SM. PLoS One. 2016 Apr 21;11(4):e0153281

3. The potential usefulness of (18)F-FDG PET/CT for detecting colorectal carcinoma and adenoma in asymptomatic adults. Hwang JP, Woo SK, Yoon SY, Jeong SY. Ann Nucl Med. 2015 Feb;29(2):157-63

4. Prognostic Value of SUVmax Measured by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography in Patients with Gallbladder Cancer. Hwang JP, Lim I, Na II, Cho EH, Kim BI, Choi CW, Lim SM. Nucl Med Mol Imaging. 2014 Jun;48(2):114-20

5. Prognostic value of SUVmax measured by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography in Patients with Pancreatic Cancer. Hwang JP, Lim I, Chang KJ, Kim BI, Choi CW, Lim SM. Nucl Med Mol Imaging. 2012 Sep;46(3):207-14

6. Clinicopathologic risk factores of radioactive iodine therapy based on response assessment in patients with differentiated thyroid cancer: a multicenter retrospective study. Kwon SY, Hwang JP, Bae SK. European Journal of Nuclear Medicine and Molecular Imaging. 2020 47:561-571 외 국내외 논문 다수 발표